Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

DexCom Inc (DXCM.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-02-15	104.37	159.994	Buy
2022-04-08	126.49	-	No Rating
2023-03-28	113.82	142.00	Buy
2023-04-28	121.34	150.00	Buy
2023-06-14	127.06	152.00	Buy
2023-07-27	129.36	175.00	Buy
2023-09-06	106.88	138.00	Buy
2023-10-26	81.09	145.00	Buy
2024-01-21	127.29	149.00	Buy
2024-02-08	127.05	153.00	Buy
2024-04-09	140.45	163.00	Buy
2024-07-26	64.00	95.00	Buy
2025-02-14	89.07	105.00	Buy

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.